Tapewire

Nasdaq · USD

BLFS

BIOLIFE SOLUTIONS INC

Export transactions ↓
Tapewire entity
4614
SEC CIK
0000834365
Parsed reports
1,001

Last 12 months

Inside the activity.

0 purchase rows · 39 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 2025014
Dec 202508
Jan 202605
Feb 202600
Mar 202609
Apr 202600
May 202603
Jun 202600
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
January 02, 2024 Filed Jan 4, 2024 22:03 UTC
Mathew Aby J.EVP & Chief Scientific Officer
SaleCommon Stock 697 $16.75 $11,674.75
Disclosure

SEC source: 0001628280-24-000468 · wk-form4_1704405819.xml · nonDerivative · entry 1

Mathew Aby J. · CIK 0001556355 · EVP & Chief Scientific Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 276,765

F1 · kind: The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 03-25-2020 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock.

Read SEC document
December 22, 2023 Filed Dec 28, 2023 21:46 UTC
Wichterman TroyChief Financial Officer
SaleCommon Stock 314 $16.79 $5,272.06
Disclosure

SEC source: 0001628280-23-042810 · wk-form4_1703800002.xml · nonDerivative · entry 1

Wichterman Troy · CIK 0001892616 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 67,339

F1 · kind: The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 06-19-2020 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock.

Read SEC document
December 17, 2023 Filed Dec 19, 2023 22:54 UTC
Wichterman TroyChief Financial Officer
GrantCommon Stock 254 Not disclosed Not disclosed
Disclosure

SEC source: 0001628280-23-042031 · wk-form4_1703026481.xml · nonDerivative · entry 1

Wichterman Troy · CIK 0001892616 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 67,366

F1 · price: The shares of restricted stock reported herein were issued to the reporting person in lieu of a portion of cash salary at the last closing price as of the date of grant.

Read SEC document
December 17, 2023 Filed Dec 19, 2023 22:55 UTC
Mathew Aby J.EVP & Chief Scientific Officer
GrantCommon Stock 705 Not disclosed Not disclosed
Disclosure

SEC source: 0001628280-23-042032 · wk-form4_1703026496.xml · nonDerivative · entry 1

Mathew Aby J. · CIK 0001556355 · EVP & Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 276,666

F1 · price: The shares of restricted stock reported herein were issued to the reporting person in lieu of a portion of cash salary at the last closing price as of the date of grant.

Read SEC document
December 17, 2023 Filed Dec 19, 2023 22:54 UTC
Foster Karen A.Chief Quality Officer
GrantCommon Stock 228 Not disclosed Not disclosed
Disclosure

SEC source: 0001628280-23-042030 · wk-form4_1703026465.xml · nonDerivative · entry 1

Foster Karen A. · CIK 0001683151 · Chief Quality Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 125,568

F1 · price: The shares of restricted stock reported herein were issued to the reporting person in lieu of a portion of cash salary at the last closing price as of the date of grant.

Read SEC document
December 17, 2023 Filed Dec 19, 2023 22:54 UTC
Phillips GeraintSVP, Global Operations
GrantCommon Stock 211 Not disclosed Not disclosed
Disclosure

SEC source: 0001628280-23-042029 · wk-form4_1703026451.xml · nonDerivative · entry 1

Phillips Geraint · CIK 0001960665 · SVP, Global Operations

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 59,798

F1 · price: The shares of restricted stock reported herein were issued to the reporting person in lieu of a portion of cash salary at the last closing price as of the date of grant.

Read SEC document
December 03, 2023 Filed Dec 21, 2023 20:44 UTC
Foster Karen A.Chief Quality Officer
GrantCommon Stock 258 Not disclosed Not disclosed
Disclosure

SEC source: 0001628280-23-042481 · wk-form4_1703191474.xml · nonDerivative · entry 1

Foster Karen A. · CIK 0001683151 · Chief Quality Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 125,826

F1 · price: The shares of restricted stock reported herein were issued to the reporting person in lieu of a portion of cash salary at the last closing price as of the date of grant.

Read SEC document
December 03, 2023 Filed Dec 21, 2023 20:44 UTC
Wichterman TroyChief Financial Officer
GrantCommon Stock 287 Not disclosed Not disclosed
Disclosure

SEC source: 0001628280-23-042480 · wk-form4_1703191464.xml · nonDerivative · entry 1

Wichterman Troy · CIK 0001892616 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 67,653

F1 · price: The shares of restricted stock reported herein were issued to the reporting person in lieu of a portion of cash salary at the last closing price as of the date of grant.

Read SEC document
December 03, 2023 Filed Dec 21, 2023 20:44 UTC
Phillips GeraintSVP, Global Operations
GrantCommon Stock 229 Not disclosed Not disclosed
Disclosure

SEC source: 0001628280-23-042479 · wk-form4_1703191454.xml · nonDerivative · entry 1

Phillips Geraint · CIK 0001960665 · SVP, Global Operations

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 60,027

F1 · price: The shares of restricted stock reported herein were issued to the reporting person in lieu of a portion of cash salary at the last closing price as of the date of grant.

Read SEC document
December 03, 2023 Filed Dec 21, 2023 20:44 UTC
Mathew Aby J.EVP & Chief Scientific Officer
GrantCommon Stock 796 Not disclosed Not disclosed
Disclosure

SEC source: 0001628280-23-042478 · wk-form4_1703191443.xml · nonDerivative · entry 1

Mathew Aby J. · CIK 0001556355 · EVP & Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 277,462

F1 · price: The shares of restricted stock reported herein were issued to the reporting person in lieu of a portion of cash salary at the last closing price as of the date of grant.

Read SEC document
December 01, 2023 Filed Dec 5, 2023 00:15 UTC
Foster Karen A.Chief Quality Officer
SaleCommon Stock 466 $12.37 $5,764.42
Disclosure

SEC source: 0001628280-23-040677 · wk-form4_1701735316.xml · nonDerivative · entry 2

Foster Karen A. · CIK 0001683151 · Chief Quality Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 125,340

F2 · kind: The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 02-24-2022 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock.

Read SEC document
December 01, 2023 Filed Dec 5, 2023 00:15 UTC
Aebersold SarahChief Human Resources Officer
SaleCommon Stock 394 $12.37 $4,873.78
Disclosure

SEC source: 0001628280-23-040676 · wk-form4_1701735302.xml · nonDerivative · entry 1

Aebersold Sarah · CIK 0001837756 · Chief Human Resources Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 43,062

F1 · kind: The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 02-24-2022 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock.

Read SEC document
December 01, 2023 Filed Dec 5, 2023 00:15 UTC
Mathew Aby J.EVP & Chief Scientific Officer
SaleCommon Stock 591 $12.37 $7,310.67
Disclosure

SEC source: 0001628280-23-040675 · wk-form4_1701735287.xml · nonDerivative · entry 2

Mathew Aby J. · CIK 0001556355 · EVP & Chief Scientific Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 275,961

F2 · kind: The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 02-24-2022 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock.

Read SEC document
December 01, 2023 Filed Dec 5, 2023 00:14 UTC
Phillips GeraintSVP, Global Operations
SaleCommon Stock 303 $12.37 $3,748.11
Disclosure

SEC source: 0001628280-23-040674 · wk-form4_1701735274.xml · nonDerivative · entry 2

Phillips Geraint · CIK 0001960665 · SVP, Global Operations

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 59,587

F2 · kind: The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 02-24-2022 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock.

Read SEC document
December 01, 2023 Filed Dec 5, 2023 00:14 UTC
Berard ToddChief Marketing Officer
SaleCommon Stock 394 $12.37 $4,873.78
Disclosure

SEC source: 0001628280-23-040673 · wk-form4_1701735258.xml · nonDerivative · entry 1

Berard Todd · CIK 0001633186 · Chief Marketing Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 117,522

F1 · kind: The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 02-24-2022 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock.

Read SEC document
December 01, 2023 Filed Dec 5, 2023 00:14 UTC
Wichterman TroyChief Financial Officer
SaleCommon Stock 666 $12.37 $8,238.42
Disclosure

SEC source: 0001628280-23-040672 · wk-form4_1701735246.xml · nonDerivative · entry 2

Wichterman Troy · CIK 0001892616 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 67,112

F2 · kind: The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 02-24-2022 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock.

Read SEC document
November 19, 2023 Filed Dec 5, 2023 00:15 UTC
Foster Karen A.Chief Quality Officer
GrantCommon Stock 267 Not disclosed Not disclosed
Disclosure

SEC source: 0001628280-23-040677 · wk-form4_1701735316.xml · nonDerivative · entry 1

Foster Karen A. · CIK 0001683151 · Chief Quality Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 125,806

F1 · price: The shares of restricted stock reported herein were issued to the reporting person in lieu of a portion of cash salary at the last closing price as of the date of grant.

Read SEC document
November 19, 2023 Filed Dec 5, 2023 00:15 UTC
Mathew Aby J.EVP & Chief Scientific Officer
GrantCommon Stock 826 Not disclosed Not disclosed
Disclosure

SEC source: 0001628280-23-040675 · wk-form4_1701735287.xml · nonDerivative · entry 1

Mathew Aby J. · CIK 0001556355 · EVP & Chief Scientific Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 276,552

F1 · price: The shares of restricted stock reported herein were issued to the reporting person in lieu of a portion of cash salary at the last closing price as of the date of grant.

Read SEC document
November 19, 2023 Filed Dec 5, 2023 00:14 UTC
Phillips GeraintSVP, Global Operations
GrantCommon Stock 234 Not disclosed Not disclosed
Disclosure

SEC source: 0001628280-23-040674 · wk-form4_1701735274.xml · nonDerivative · entry 1

Phillips Geraint · CIK 0001960665 · SVP, Global Operations

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 59,890

F1 · price: The shares of restricted stock reported herein were issued to the reporting person in lieu of a portion of cash salary at the last closing price as of the date of grant.

Read SEC document
November 19, 2023 Filed Dec 5, 2023 00:14 UTC
Wichterman TroyChief Financial Officer
GrantCommon Stock 298 Not disclosed Not disclosed
Disclosure

SEC source: 0001628280-23-040672 · wk-form4_1701735246.xml · nonDerivative · entry 1

Wichterman Troy · CIK 0001892616 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 67,778

F1 · price: The shares of restricted stock reported herein were issued to the reporting person in lieu of a portion of cash salary at the last closing price as of the date of grant.

Read SEC document
November 13, 2023 Filed Nov 15, 2023 15:41 UTC
Foster Karen A.Chief Quality Officer
SaleCommon Stock 114 $10.77 $1,227.78
Disclosure

SEC source: 0001628280-23-039100 · wk-form4_1700062902.xml · nonDerivative · entry 1

Foster Karen A. · CIK 0001683151 · Chief Quality Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 125,539

F1 · kind: The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 02-08-2021 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock.

Read SEC document
November 13, 2023 Filed Nov 15, 2023 15:41 UTC
Aebersold SarahChief Human Resources Officer
SaleCommon Stock 76 $10.77 $818.52
Disclosure

SEC source: 0001628280-23-039099 · wk-form4_1700062891.xml · nonDerivative · entry 1

Aebersold Sarah · CIK 0001837756 · Chief Human Resources Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 43,456

F1 · kind: The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 02-08-2021 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock.

Read SEC document
November 13, 2023 Filed Nov 15, 2023 15:41 UTC
Berard ToddChief Marketing Officer
SaleCommon Stock 98 $10.77 $1,055.46
Disclosure

SEC source: 0001628280-23-039098 · wk-form4_1700062879.xml · nonDerivative · entry 1

Berard Todd · CIK 0001633186 · Chief Marketing Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 117,916

F1 · kind: The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 02-08-2021 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock.

Read SEC document
November 13, 2023 Filed Nov 15, 2023 15:41 UTC
Phillips GeraintSVP, Global Operations
SaleCommon Stock 111 $10.66 $1,183.26
Disclosure

SEC source: 0001628280-23-039097 · wk-form4_1700062865.xml · nonDerivative · entry 1

Phillips Geraint · CIK 0001960665 · SVP, Global Operations

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 59,656

F1 · kind: The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 08-09-2021 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock.

Read SEC document
November 13, 2023 Filed Nov 15, 2023 15:41 UTC
Mathew Aby J.EVP & Chief Scientific Officer
SaleCommon Stock 132 $10.77 $1,421.64
Disclosure

SEC source: 0001628280-23-039096 · wk-form4_1700062853.xml · nonDerivative · entry 1

Mathew Aby J. · CIK 0001556355 · EVP & Chief Scientific Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 275,726

F1 · kind: The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 02-08-2021 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock.

Read SEC document
November 13, 2023 Filed Nov 15, 2023 15:40 UTC
Wichterman TroyChief Financial Officer
SaleCommon Stock 97 $10.66 $1,034.02
Disclosure

SEC source: 0001628280-23-039095 · wk-form4_1700062841.xml · nonDerivative · entry 1

Wichterman Troy · CIK 0001892616 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 67,480

F1 · kind: The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 08-09-2021 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock.

Read SEC document
November 05, 2023 Filed Nov 13, 2023 21:41 UTC
Foster Karen A.Chief Quality Officer
GrantCommon Stock 299 Not disclosed Not disclosed
Disclosure

SEC source: 0001628280-23-038654 · wk-form4_1699911667.xml · nonDerivative · entry 1

Foster Karen A. · CIK 0001683151 · Chief Quality Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 125,653

F1 · price: The shares of restricted stock reported herein were issued to the reporting person in lieu of a portion of cash salary at the last closing price as of the date of grant.

Read SEC document
November 05, 2023 Filed Nov 13, 2023 21:41 UTC
Phillips GeraintSVP, Global Operations
GrantCommon Stock 262 Not disclosed Not disclosed
Disclosure

SEC source: 0001628280-23-038653 · wk-form4_1699911654.xml · nonDerivative · entry 1

Phillips Geraint · CIK 0001960665 · SVP, Global Operations

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 59,767

F1 · price: The shares of restricted stock reported herein were issued to the reporting person in lieu of a portion of cash salary at the last closing price as of the date of grant.

Read SEC document
November 05, 2023 Filed Nov 13, 2023 21:40 UTC
Wichterman TroyChief Financial Officer
GrantCommon Stock 333 Not disclosed Not disclosed
Disclosure

SEC source: 0001628280-23-038652 · wk-form4_1699911624.xml · nonDerivative · entry 1

Wichterman Troy · CIK 0001892616 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 67,577

F1 · price: The shares of restricted stock reported herein were issued to the reporting person in lieu of a portion of cash salary at the last closing price as of the date of grant.

Read SEC document
November 05, 2023 Filed Nov 13, 2023 21:40 UTC
Mathew Aby J.EVP & Chief Scientific Officer
GrantCommon Stock 924 Not disclosed Not disclosed
Disclosure

SEC source: 0001628280-23-038651 · wk-form4_1699911598.xml · nonDerivative · entry 1

Mathew Aby J. · CIK 0001556355 · EVP & Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 275,858

F1 · price: The shares of restricted stock reported herein were issued to the reporting person in lieu of a portion of cash salary at the last closing price as of the date of grant.

Read SEC document
November 01, 2023 Filed Nov 3, 2023 21:10 UTC GrantCommon Stock 608 Not disclosed Not disclosed
Disclosure

SEC source: 0001628280-23-036782 · wk-form4_1699045830.xml · nonDerivative · entry 1

Schick Joseph C · CIK 0001592238 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 32,689

F1 · price: The shares of restricted stock reported herein were issued to the reporting person in lieu of a portion of cash director fees at the last closing price as of the date of grant.

Read SEC document
November 01, 2023 Filed Nov 3, 2023 21:10 UTC GrantCommon Stock 577 Not disclosed Not disclosed
Disclosure

SEC source: 0001628280-23-036781 · wk-form4_1699045814.xml · nonDerivative · entry 1

GOSWAMI JOYDEEP · CIK 0001533115 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 29,846

F1 · price: The shares of restricted stock reported herein were issued to the reporting person in lieu of a portion of cash director fees at the last closing price as of the date of grant.

Read SEC document
November 01, 2023 Filed Nov 3, 2023 21:10 UTC GrantCommon Stock 495 Not disclosed Not disclosed
Disclosure

SEC source: 0001628280-23-036780 · wk-form4_1699045799.xml · nonDerivative · entry 1

Ellingson Rachel · CIK 0001557271 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 31,685

F1 · price: The shares of restricted stock reported herein were issued to the reporting person in lieu of a portion of cash director fees at the last closing price as of the date of grant.

Read SEC document
November 01, 2023 Filed Nov 3, 2023 21:09 UTC
DuRoss AmyDirector
GrantCommon Stock 598 Not disclosed Not disclosed
Disclosure

SEC source: 0001628280-23-036779 · wk-form4_1699045788.xml · nonDerivative · entry 1

DuRoss Amy · CIK 0001854968 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 29,379

F1 · price: The shares of restricted stock reported herein were issued to the reporting person in lieu of a portion of cash director fees at the last closing price as of the date of grant.

Read SEC document
November 01, 2023 Filed Nov 3, 2023 21:09 UTC GrantCommon Stock 495 Not disclosed Not disclosed
Disclosure

SEC source: 0001628280-23-036778 · wk-form4_1699045777.xml · nonDerivative · entry 1

MOORE TIMOTHY L. · CIK 0001669207 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 18,633

F1 · price: The shares of restricted stock reported herein were issued to the reporting person in lieu of a portion of cash director fees at the last closing price as of the date of grant.

Read SEC document
October 30, 2023 Filed Nov 1, 2023 21:30 UTC
Rice MichaelFormer CEO and Director
SaleCommon Stock 72,603 $9.13 $662,865.39
Disclosure

SEC source: 0001628280-23-036053 · wk-form4_1698874195.xml · nonDerivative · entry 1

Rice Michael · CIK 0001389512 · Former CEO and Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 347,085

F1 · kind: The sale reported herein was made pursuant to Rule 10b5-1 (c) trading plans adopted by the reporting person effective as of 03-25-2020, 02-08-21, 02-24-2022, and 01-03-2023 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock.

Read SEC document
October 22, 2023 Filed Oct 24, 2023 23:45 UTC
Phillips GeraintSVP, Global Operations
GrantCommon Stock 291 Not disclosed Not disclosed
Disclosure

SEC source: 0001628280-23-035028 · wk-form4_1698191134.xml · nonDerivative · entry 1

Phillips Geraint · CIK 0001960665 · SVP, Global Operations

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 59,505

F1 · price: The shares of restricted stock reported herein were issued to the reporting person in lieu of a portion of cash salary at the last closing price as of the date of grant.

Read SEC document
October 22, 2023 Filed Oct 24, 2023 23:46 UTC
Foster Karen A.Chief Quality Officer
GrantCommon Stock 335 Not disclosed Not disclosed
Disclosure

SEC source: 0001628280-23-035029 · wk-form4_1698191164.xml · nonDerivative · entry 1

Foster Karen A. · CIK 0001683151 · Chief Quality Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 125,354

F1 · price: The shares of restricted stock reported herein were issued to the reporting person in lieu of a portion of cash salary at the last closing price as of the date of grant.

Read SEC document
October 22, 2023 Filed Oct 24, 2023 23:45 UTC
Rice MichaelFormer CEO and Director
GrantCommon Stock 771 Not disclosed Not disclosed
Disclosure

SEC source: 0001628280-23-035027 · wk-form4_1698191120.xml · nonDerivative · entry 1

Rice Michael · CIK 0001389512 · Former CEO and Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 419,688

F1 · price: The shares of restricted stock reported herein were issued to the reporting person in lieu of a portion of cash salary at the last closing price as of the date of grant.

Read SEC document
October 22, 2023 Filed Oct 24, 2023 23:45 UTC
Mathew Aby J.EVP & Chief Scientific Officer
GrantCommon Stock 1,034 Not disclosed Not disclosed
Disclosure

SEC source: 0001628280-23-035026 · wk-form4_1698191102.xml · nonDerivative · entry 1

Mathew Aby J. · CIK 0001556355 · EVP & Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 274,934

F1 · price: The shares of restricted stock reported herein were issued to the reporting person in lieu of a portion of cash salary at the last closing price as of the date of grant.

Read SEC document
October 22, 2023 Filed Oct 24, 2023 23:44 UTC
Wichterman TroyChief Financial Officer
GrantCommon Stock 373 Not disclosed Not disclosed
Disclosure

SEC source: 0001628280-23-035025 · wk-form4_1698191090.xml · nonDerivative · entry 1

Wichterman Troy · CIK 0001892616 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 67,244

F1 · price: The shares of restricted stock reported herein were issued to the reporting person in lieu of a portion of cash salary at the last closing price as of the date of grant.

Read SEC document
October 19, 2023 Filed Oct 23, 2023 21:42 UTC
Casdin Eli10% owner
PurchaseCommon Stock, par value $.001 per share 927,165 $11.19 $10,374,976.35
Disclosure

SEC source: 0000919574-23-005783 · ownership.xml · nonDerivative · entry 1

Casdin Partners Master Fund, L.P. · CIK 0001534265 · 10% owner

Casdin Capital, LLC · CIK 0001534261 · 10% owner

Casdin Partners GP, LLC · CIK 0001534260 · 10% owner

Casdin Eli · CIK 0001534264 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,557,165

F1 · ownership.direct: The securities are owned directly by the Casdin Partners Master Fund, L.P. (the "Master Fund") and may be deemed to be indirectly beneficially owned by (i) Casdin Capital, LLC ("Casdin Capital"), the investment adviser to the Master Fund, (ii) Casdin Partners GP, LLC ("Casdin GP"), the general partner of the Master Fund, and (iii) Eli Casdin, the managing member of Casdin Capital and Casdin GP.

Read SEC document
October 19, 2023 Filed Nov 1, 2023 21:29 UTC
DE GREEF RODERICKDirector · President and CEO
GrantRestricted Stock Award · Derivative 394,856 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001628280-23-036052 · wk-form4_1698874183.xml · derivative · entry 2

DE GREEF RODERICK · CIK 0001241181 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 394,856

Underlying: Common Stock · 394,856 shares

Expires not disclosed

F3 · shares: The restricted stock was granted pursuant to the Executive Employment Agreement. The restricted stock will vest in equal annual installments so long as the reporting owner remains employed by the registrant through January 1, 2027.

F3 · derivative.exercise_date: The restricted stock was granted pursuant to the Executive Employment Agreement. The restricted stock will vest in equal annual installments so long as the reporting owner remains employed by the registrant through January 1, 2027.

F3 · derivative.expiration_date: The restricted stock was granted pursuant to the Executive Employment Agreement. The restricted stock will vest in equal annual installments so long as the reporting owner remains employed by the registrant through January 1, 2027.

Read SEC document
October 19, 2023 Filed Nov 1, 2023 21:29 UTC
DE GREEF RODERICKDirector · President and CEO
GrantCommon Stock 394,856 Not disclosed Not disclosed
Disclosure

SEC source: 0001628280-23-036052 · wk-form4_1698874183.xml · nonDerivative · entry 1

DE GREEF RODERICK · CIK 0001241181 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 442,539

F1 · price: The restricted stock was granted pursuant to the BioLife Solutions 2023 Omnibus Performance Incentive Plan and vests 25% on the first anniversary of the grant date and thereafter quarterly, in 12 equal quarterly installments. The restricted stock was granted to the reporting person as part of their employment agreement.

F2 · balance_after: This reflects the total amount beneficially owned by the reporting person as of October 19, 2023. Previous Form 4's filed by the reporting person before October 19, 2023 did not reflect the acquisition of 2,421 shares.

Read SEC document
October 19, 2023 Filed Nov 1, 2023 21:29 UTC
Richardson GarrieChief Revenue Officer
GrantCommon Stock 36,320 Not disclosed Not disclosed
Disclosure

SEC source: 0001628280-23-036051 · wk-form4_1698874172.xml · nonDerivative · entry 1

Richardson Garrie · CIK 0001999183 · Chief Revenue Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 105,327

F1 · price: The restricted stock was granted pursuant to the BioLife Solutions 2023 Omnibus Performance Incentive Plan (the "Plan") and vests 25% on the first anniversary of the grant date and thereafter annually, in 4 equal quarterly installments. The restricted stock was granted to the reporting person as part of 2023 compensation in connection with their appointment as Chief Revenue Officer.

Read SEC document
October 08, 2023 Filed Oct 10, 2023 21:26 UTC
Mathew Aby J.EVP & Chief Scientific Officer
GrantCommon Stock 779 Not disclosed Not disclosed
Disclosure

SEC source: 0001628280-23-034203 · wk-form4_1696973159.xml · nonDerivative · entry 1

Mathew Aby J. · CIK 0001556355 · EVP & Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 273,900

F1 · price: The shares of restricted stock reported herein were issued to the reporting person in lieu of a portion of cash salary at the last closing price as of the date of grant.

Read SEC document
October 08, 2023 Filed Oct 10, 2023 21:25 UTC
Phillips GeraintSVP, Global Operations
GrantCommon Stock 219 Not disclosed Not disclosed
Disclosure

SEC source: 0001628280-23-034202 · wk-form4_1696973147.xml · nonDerivative · entry 1

Phillips Geraint · CIK 0001960665 · SVP, Global Operations

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 59,214

F1 · price: The shares of restricted stock reported herein were issued to the reporting person in lieu of a portion of cash salary at the last closing price as of the date of grant.

Read SEC document
October 08, 2023 Filed Oct 10, 2023 21:25 UTC
Foster Karen A.Chief Quality Officer
GrantCommon Stock 252 Not disclosed Not disclosed
Disclosure

SEC source: 0001628280-23-034201 · wk-form4_1696973135.xml · nonDerivative · entry 1

Foster Karen A. · CIK 0001683151 · Chief Quality Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 125,019

F1 · price: The shares of restricted stock reported herein were issued to the reporting person in lieu of a portion of cash salary at the last closing price as of the date of grant.

Read SEC document
October 08, 2023 Filed Oct 10, 2023 21:25 UTC
Rice MichaelDirector · Chief Executive Officer
GrantCommon Stock 282 Not disclosed Not disclosed
Disclosure

SEC source: 0001628280-23-034200 · wk-form4_1696973124.xml · nonDerivative · entry 1

Rice Michael · CIK 0001389512 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 418,917

F1 · price: The shares of restricted stock reported herein were issued to the reporting person in lieu of a portion of cash salary at the last closing price as of the date of grant.

Read SEC document
October 08, 2023 Filed Oct 10, 2023 21:25 UTC
Wichterman TroyChief Financial Officer
GrantCommon Stock 281 Not disclosed Not disclosed
Disclosure

SEC source: 0001628280-23-034199 · wk-form4_1696973109.xml · nonDerivative · entry 1

Wichterman Troy · CIK 0001892616 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 66,871

F1 · price: The shares of restricted stock reported herein were issued to the reporting person in lieu of a portion of cash salary at the last closing price as of the date of grant.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.